Targimmune Therapeutics

Developer of drugs for treating cancer

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2016 groups21 employees language targimmune.com

Innovation

5 patent families — focus: Human necessities; filing pace accelerating. Cited 6 times.

YearFilings
20231
20241
20253

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Accelerator & incubator125%
Other / undisclosed125%
Coming soon